Clinical Trial

Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-23.
Trial Details
NCT Number NCT07495852
Lead Sponsor Glaukos Corporation
Conditions Glaucoma
Enrollment 510 participants
Start Date 2026-02-17
Primary Completion 2028-06 (estimated)
Study Completion 2032-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-30